// App-Quantinova.ai

89 : The Risk of Major Bleeding with Low-Molecular-Weight-Heparins for Venous Thromboembolism in Dialysis Patients: The Q-VTE Study

Researchers

Presenter

  • Adi J. Klil-Drori

Principal Investigators

  • Janie Coulombe

  • Sharon J. Nessim

  • Vicky Tagalakis

Medical Centers

  • Department of Oncology, McGill University, Montreal, QC, Canada

  • Centre for Clinical Epidemiology, Jewish General Hospital, Montreal, QC, Canada

  • Department of Oncology, McGill University, Montreal, QC, Canada

  • Department of Medicine, Sir Mortimer B. Davis Jewish General Hospital, Montreal, QC, Canada

  • Division of Nephrology, Department of Medicine, Jewish General Hospital, Montreal, QC, Canada

  • Center for Clinical Epidemiology, Lady Davis Institute, Montreal, QC, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved